Follow
Eli Chapman
Eli Chapman
Verified email at pharmacy.arizona.edu
Title
Cited by
Cited by
Year
NRF2 and the Hallmarks of Cancer
MR de la Vega, E Chapman, DD Zhang
Cancer cell 34 (1), 21-43, 2018
10572018
Two families of chaperonin: physiology and mechanism
AL Horwich, WA Fenton, E Chapman, GW Farr
Annu. Rev. Cell Dev. Biol. 23, 115-145, 2007
5372007
p62 links autophagy and Nrf2 signaling
T Jiang, B Harder, MR De La Vega, PK Wong, E Chapman, DD Zhang
Free Radical Biology and Medicine 88, 199-204, 2015
5352015
Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility
E Chapman, MD Best, SR Hanson, CH Wong
Angewandte Chemie International Edition 43 (27), 3526-3548, 2004
3792004
Modulating NRF2 in disease: timing is everything
M Dodson, MR de la Vega, AB Cholanians, CJ Schmidlin, E Chapman, ...
Annual review of pharmacology and toxicology 59, 555-575, 2019
3552019
Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis
T Wu, F Zhao, B Gao, C Tan, N Yagishita, T Nakajima, PK Wong, ...
Genes & development 28 (7), 708-722, 2014
3272014
Oncogenic KRAS confers chemoresistance by upregulating NRF2
S Tao, S Wang, SJ Moghaddam, A Ooi, E Chapman, PK Wong, DD Zhang
Cancer research 74 (24), 7430-7441, 2014
2762014
Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention
B Harder, T Jiang, T Wu, S Tao, MR de la Vega, W Tian, E Chapman, ...
Biochemical Society Transactions 43 (4), 680-686, 2015
1752015
Global aggregation of newly translated proteins in an Escherichia coli strain deficient of the chaperonin GroEL
E Chapman, GW Farr, R Usaite, K Furtak, WA Fenton, TK Chaudhuri, ...
Proceedings of the National Academy of Sciences 103 (43), 15800-15805, 2006
1512006
Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides
MD Burkart, M Izumi, E Chapman, CH Lin, CH Wong
The Journal of organic chemistry 65 (18), 5565-5574, 2000
1372000
Non-enzymatic lysine lactoylation of glycolytic enzymes
DO Gaffney, EQ Jennings, CC Anderson, JO Marentette, T Shi, ...
Cell chemical biology 27 (2), 206-213. e6, 2020
1292020
USP15 negatively regulates Nrf2 through deubiquitination of Keap1
NF Villeneuve, W Tian, T Wu, Z Sun, A Lau, E Chapman, D Fang, ...
Molecular cell 51 (1), 68-79, 2013
1132013
The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer
S Tao, M Rojo de la Vega, E Chapman, A Ooi, DD Zhang
Molecular carcinogenesis 57 (2), 182-192, 2018
1092018
Brusatol overcomes chemoresistance through inhibition of protein translation
B Harder, W Tian, JJ La Clair, AC Tan, A Ooi, E Chapman, DD Zhang
Molecular carcinogenesis 56 (5), 1493-1500, 2017
1062017
Mutational analysis of backbone hydrogen bonds in staphylococcal nuclease
E Chapman, JS Thorson, PG Schultz
Journal of the American Chemical Society 119 (30), 7151-7152, 1997
1011997
Inhibitors of the AAA+ chaperone p97
E Chapman, N Maksim, F De la Cruz, JJ La Clair
Molecules 20 (2), 3027-3049, 2015
1002015
p97 negatively regulates NRF2 by extracting ubiquitylated NRF2 from the KEAP1-CUL3 E3 complex
S Tao, P Liu, G Luo, M Rojo de la Vega, H Chen, T Wu, J Tillotson, ...
Molecular and cellular biology 37 (8), e00660-16, 2017
932017
The complexities of p97 function in health and disease
E Chapman, AN Fry, MJ Kang
Molecular bioSystems 7 (3), 700-710, 2011
872011
A curcumin derivative that inhibits vinyl carbamate-induced lung carcinogenesis via activation of the Nrf2 protective response
T Shen, T Jiang, M Long, J Chen, DM Ren, PK Wong, E Chapman, ...
Antioxidants & redox signaling 23 (8), 651-664, 2015
812015
Role of Nrf2 and autophagy in acute lung injury
MR de la Vega, M Dodson, C Gross, HM Mansour, RC Lantz, E Chapman, ...
Current pharmacology reports 2, 91-101, 2016
802016
The system can't perform the operation now. Try again later.
Articles 1–20